RNA sequencing of human CRC PDOs treated with Cetuximab versus MCLA-158

ABSTRACT: We profiled 2 PDOs (P18T and C55T) in control medium, Cetuximab or MCLA-158 treatment during 48 hours at 2 concentrations

ORGANISM(S): Homo sapiens

PROVIDER: GSE186531 | GEO | 2022/02/15

REPOSITORIES: GEO